{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:44:43Z","timestamp":1792565083783,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Bloodstream infections (BSIs) remain a major cause of morbidity and mortality in patients undergoing chemotherapy. The rising incidence of multidrug-resistant organisms (MDROs) further challenges the adequacy of empirical antimicrobial therapy. Therefore, this study aimed to identify features associated with different microbiological profiles of BSIs in chemotherapy patients using machine learning models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 1435 confirmed BSI episodes among 1220 patients treated at a tertiary cancer center from 2017 to 2022. A multi-label classification approach was used to model BSIs associated with carbapenem-resistant Gram-negative bacilli (CR-GNB), methicillin-resistant staphylococci, third-generation cephalosporin-resistant Enterobacterales (3GCRE), fungal pathogens, and non-MDRO\/non-fungal. Classifier chain models based on logistic regression, random forests, neural networks, and gradient boosting were trained and evaluated using cross-validation with an independent test set. Model outputs were interpreted using SHapley Additive exPlanations (SHAP) to estimate feature contributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most BSIs occurred during the first chemotherapy cycle and were due to non-MDROs or fungal agents (1193 episodes; 83.1%), CR-GNB was identified in 109 (7.6%). Model performance varied across pathogen groups, with the highest discrimination observed for CR-GNB (AUC-ROC 83.25%; 95% CI 73.91%\u201391.64%). Key features included hospitalization days, hematologic malignancy, prior MDRO infection, monocytopenia, and palliative chemotherapy. Chemotherapy class contributed differently across pathogen groups, with alkylating agents contributing to candidemia, antitumor antibiotics to CR-GNB, and antimetabolites to 3GCRE. Prior CR-GNB infection was the strongest predictor for CR-GNB BSI, while palliative chemotherapy correlated with non-MDRO\/non-fungal BSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Multi-label machine learning approaches may help disentangle the complex etiologies of BSIs in cancer patients by identifying associations between host factors, prior MDRO infection, and chemotherapy class within confirmed BSI episodes, informing future hypothesis generation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11379-2","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:54:44Z","timestamp":1792508084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of machine learning to identify risk factors for bloodstream infections caused by different antimicrobial resistance phenotypes in chemotherapy patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Adhemar","family":"Villani Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-192X","authenticated-orcid":false,"given":"Maristela P.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"De Padua Covas Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felippe","family":"Lazar Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura Salaroli","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima L. S.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sara S.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"11379_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36:1443\u20131453. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211","journal-title":"J Clin Oncol"},{"key":"11379_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/cid\/ciz319","volume":"70","author":"G Martinez-Nadal","year":"2020","unstructured":"Martinez-Nadal G, Puerta-Alcalde P, Gudiol C et al (2020) Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis 70:1068\u20131074. https:\/\/doi.org\/10.1093\/cid\/ciz319","journal-title":"Clin Infect Dis"},{"key":"11379_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02961-23","author":"C Lopera","year":"2024","unstructured":"Lopera C, Monz\u00f3 P, Aiello TF et al (2024) Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.02961-23","journal-title":"Microbiol Spectr"},{"key":"11379_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00277-021-04541-9","volume":"100","author":"S Weber","year":"2021","unstructured":"Weber S, Magh A, Hogardt M et al (2021) Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis. Ann Hematol 100:1593\u20131602. https:\/\/doi.org\/10.1007\/s00277-021-04541-9","journal-title":"Ann Hematol"},{"key":"11379_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1470-2045(25)00128-7","volume":"26","author":"V Gupta","year":"2025","unstructured":"Gupta V, Satlin MJ, Yu KC et al (2025) Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncol 26:620\u2013628. https:\/\/doi.org\/10.1016\/S1470-2045(25)00128-7","journal-title":"Lancet Oncol"},{"key":"11379_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66524-w","volume":"14","author":"K-H Park","year":"2024","unstructured":"Park K-H, Jung YJ, Lee HJ et al (2024) Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections. Sci Rep 14:15622. https:\/\/doi.org\/10.1038\/s41598-024-66524-w","journal-title":"Sci Rep"},{"key":"11379_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12879-021-05763-y","volume":"21","author":"Z Li","year":"2021","unstructured":"Li Z, Zhuang H, Wang G et al (2021) Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis. BMC Infect Dis 21:74. https:\/\/doi.org\/10.1186\/s12879-021-05763-y","journal-title":"BMC Infect Dis"},{"key":"11379_CR8","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.2147\/IDR.S515530","volume":"18","author":"M Jing","year":"2025","unstructured":"Jing M, Wang X, Li W et al (2025) Clinical characteristics, risk factors and prognosis of carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in cancer patients: an 8-year retrospective study in a tertiary cancer hospital. Infect Drug Resist 18:2511\u20132524. https:\/\/doi.org\/10.2147\/IDR.S515530","journal-title":"Infect Drug Resist"},{"key":"11379_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235561","volume":"15","author":"B de Dios-Garc\u00eda","year":"2023","unstructured":"de Dios-Garc\u00eda B, Maestro G, D\u00edaz-Pedroche C et al (2023) Bacteremia in patients with solid organ cancer: insights into epidemiology and antibiotic consumption. Cancers (Basel) 15:5561. https:\/\/doi.org\/10.3390\/cancers15235561","journal-title":"Cancers (Basel)"},{"key":"11379_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63864-5","volume":"14","author":"Z Ma","year":"2024","unstructured":"Ma Z, Lai C, Zhang J et al (2024) High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections. Sci Rep 14:13041. https:\/\/doi.org\/10.1038\/s41598-024-63864-5","journal-title":"Sci Rep"},{"key":"11379_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jiac.2024.03.013","volume":"30","author":"M Lee","year":"2024","unstructured":"Lee M, Lee CM, Byun J et al (2024) Risk factors for resistant Gram-positive bacteremia in febrile neutropenic patients with cancer. J Infect Chemother 30:995\u20131000. https:\/\/doi.org\/10.1016\/j.jiac.2024.03.013","journal-title":"J Infect Chemother"},{"key":"11379_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MPH.0000000000002974","volume":"47","author":"JS Park","year":"2025","unstructured":"Park JS, Song J, Yoo R et al (2025) Machine learning\u2013based prediction of blood stream infection in pediatric febrile neutropenia. J Pediatr Hematol Oncol 47:12\u201318. https:\/\/doi.org\/10.1097\/MPH.0000000000002974","journal-title":"J Pediatr Hematol Oncol"},{"key":"11379_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40121-021-00438-2","volume":"10","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Puerta-Alcalde P, Cardozo C et al (2021) Machine learning to assess the risk of multidrug-resistant Gram-negative bacilli infections in febrile neutropenic hematological patients. Infect Dis Ther 10:971\u2013983. https:\/\/doi.org\/10.1007\/s40121-021-00438-2","journal-title":"Infect Dis Ther"},{"key":"11379_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115516","volume":"223","author":"A Villani J\u00fanior","year":"2025","unstructured":"Villani J\u00fanior A, Freire MP, Lazar Neto F et al (2025) Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy. Eur J Cancer 223:115516. https:\/\/doi.org\/10.1016\/j.ejca.2025.115516","journal-title":"Eur J Cancer"},{"key":"11379_CR15","unstructured":"CDC-NHSN (2025) Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection) bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infect. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/4psc_clabscurrent.pdf. Accessed 1 Feb 2025"},{"key":"11379_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106183","volume":"89","author":"X Yang","year":"2024","unstructured":"Yang X, Li X, Qiu S et al (2024) Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data. J Infect 89:106183. https:\/\/doi.org\/10.1016\/j.jinf.2024.106183","journal-title":"J Infect"},{"key":"11379_CR17","unstructured":"Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., ... & Duchesnay \u00c9 (2011) Scikit-learn: machine learning in Python. J Mach Learn Res 12:2825\u20132830. http:\/\/jmlr.org\/papers\/v12\/pedregosa11a.html"},{"key":"11379_CR18","doi-asserted-by":"crossref","unstructured":"Read J, Pfahringer B, Holmes G, Frank E (2009) Classifier chains for multi-label classification. pp 254\u2013269","DOI":"10.1007\/978-3-642-04174-7_17"},{"key":"11379_CR19","doi-asserted-by":"publisher","unstructured":"Lundberg SM, Lee SI (2017) A unified approach to interpreting model predictions. Adv Neural Inf Process Syst 30:4765\u20134774. https:\/\/doi.org\/10.48550\/arXiv.1705.07874","DOI":"10.48550\/arXiv.1705.07874"},{"key":"11379_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jac\/dkae416","volume":"80","author":"M Tumbarello","year":"2025","unstructured":"Tumbarello M, Giuliano G, Criscuolo M et al (2025) Clinical impact of ceftazidime\/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study. J Antimicrob Chemother 80:386\u2013398. https:\/\/doi.org\/10.1093\/jac\/dkae416","journal-title":"J Antimicrob Chemother"},{"key":"11379_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ijantimicag.2016.08.021","volume":"48","author":"M Alevizakos","year":"2016","unstructured":"Alevizakos M, Karanika S, Detsis M, Mylonakis E (2016) Colonisation with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 48:647\u2013654. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.08.021","journal-title":"Int J Antimicrob Agents"},{"key":"11379_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02494-19","author":"C Gudiol","year":"2020","unstructured":"Gudiol C, Albasanz-Puig A, Laporte-Amarg\u00f3s J et al (2020) Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02494-19","journal-title":"Antimicrob Agents Chemother"},{"key":"11379_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02478-22","author":"AC Nolan","year":"2023","unstructured":"Nolan AC, Zeden MS, Kviatkovski I et al (2023) Purine nucleosides interfere with c-di-AMP levels and act as adjuvants to re-sensitize MRSA to \u03b2-lactam antibiotics. MBio. https:\/\/doi.org\/10.1128\/mbio.02478-22","journal-title":"MBio"},{"key":"11379_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/annonc\/mdj092","volume":"17","author":"Y Lalami","year":"2006","unstructured":"Lalami Y, Paesmans M, Muanza F et al (2006) Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis. Ann Oncol 17:507\u2013514. https:\/\/doi.org\/10.1093\/annonc\/mdj092","journal-title":"Ann Oncol"},{"key":"11379_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910255","volume":"25","author":"P Guevara-Ram\u00edrez","year":"2024","unstructured":"Guevara-Ram\u00edrez P, Cadena-Ullauri S, Paz-Cruz E et al (2024) Gut microbiota disruption in hematologic cancer therapy: molecular insights and implications for treatment efficacy. Int J Mol Sci 25:10255. https:\/\/doi.org\/10.3390\/ijms251910255","journal-title":"Int J Mol Sci"},{"key":"11379_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/antibiotics14030264","volume":"14","author":"MJ Kenneth","year":"2025","unstructured":"Kenneth MJ, Wu C-C, Fang C-Y et al (2025) Exploring the impact of chemotherapy on the emergence of antibiotic resistance in the gut microbiota of colorectal cancer patients. Antibiotics (Basel) 14:264. https:\/\/doi.org\/10.3390\/antibiotics14030264","journal-title":"Antibiotics (Basel)"},{"key":"11379_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41598-020-57505-w","volume":"10","author":"CA Hobson","year":"2020","unstructured":"Hobson CA, Bonacorsi S, Hocquet D et al (2020) Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam. Sci Rep 10:589. https:\/\/doi.org\/10.1038\/s41598-020-57505-w","journal-title":"Sci Rep"},{"key":"11379_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14787210.2018.1536546","volume":"16","author":"MW McCarthy","year":"2018","unstructured":"McCarthy MW, Walsh TJ (2018) Candidemia in the cancer patient: diagnosis, treatment, and future directions. Expert Rev Anti Infect Ther 16:849\u2013854. https:\/\/doi.org\/10.1080\/14787210.2018.1536546","journal-title":"Expert Rev Anti Infect Ther"},{"key":"11379_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/JCO.1996.14.3.919","volume":"14","author":"WR Rackoff","year":"1996","unstructured":"Rackoff WR, Gonin R, Robinson C et al (1996) Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol 14:919\u2013924. https:\/\/doi.org\/10.1200\/JCO.1996.14.3.919","journal-title":"J Clin Oncol"},{"key":"11379_CR30","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1182\/blood.V96.9.3290","volume":"96","author":"J Storek","year":"2000","unstructured":"Storek J, Espino G, Dawson MA et al (2000) Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 96:3290\u20133293. https:\/\/doi.org\/10.1182\/blood.V96.9.3290","journal-title":"Blood"},{"key":"11379_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820\u2013831. https:\/\/doi.org\/10.1002\/cncr.22484","journal-title":"Cancer"},{"key":"11379_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaf103","author":"M Endashaw","year":"2025","unstructured":"Endashaw M, Dykes A, Clark R et al (2025) Impact of COVID-19 on candidemia: risk factors and outcomes in a southeastern US cohort. Med Mycol. https:\/\/doi.org\/10.1093\/mmy\/myaf103","journal-title":"Med Mycol"},{"key":"11379_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107043","volume":"63","author":"H Luo","year":"2024","unstructured":"Luo H, Chen X, Jiang Z, Yan Q (2024) Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: a systematic review and meta-analysis. Int J Antimicrob Agents 63:107043. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107043","journal-title":"Int J Antimicrob Agents"},{"key":"11379_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/cid\/ciae110","volume":"79","author":"E Temkin","year":"2024","unstructured":"Temkin E, Solter E, Lugassy C et al (2024) The natural history of carbapenemase-producing Enterobacterales: progression from carriage of various carbapenemases to bloodstream infection. Clin Infect Dis 79:22\u201329. https:\/\/doi.org\/10.1093\/cid\/ciae110","journal-title":"Clin Infect Dis"},{"key":"11379_CR35","doi-asserted-by":"publisher","unstructured":"Microbiol C, Chen X, Wen X et al (2023) Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization. Ann Clin Microbiol Antimicrob. https:\/\/doi.org\/10.1186\/s12941-023-00554-6","DOI":"10.1186\/s12941-023-00554-6"},{"key":"11379_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/mdr.2021.0253","volume":"28","author":"D Averbuch","year":"2022","unstructured":"Averbuch D, Moshkovitz L, Ilan S et al (2022) Bacteremia with carbapenemase-producing Enterobacterales in immunocompromised patients colonized with these bacteria. Microb Drug Resist 28:593\u2013600. https:\/\/doi.org\/10.1089\/mdr.2021.0253","journal-title":"Microb Drug Resist"},{"key":"11379_CR37","doi-asserted-by":"crossref","unstructured":"Cattaneo C, Blasi R Di, Skert C et al (2018) Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. pp 1717\u20131726","DOI":"10.1007\/s00277-018-3341-6"},{"key":"11379_CR38","unstructured":"Dina Averbuch, Manuela Aguilar Guisado MA, Francesco Baccelli, Nicole Blijlevens, Catherine Cordonnier, Carol Garcia Vidal, Malgorzata Mikulska PM, Dionysos Neofytos, Yuri Vanbiervliet TC (2024) 10th ECIL - bacterial: febrile neutropenia \u2013 duration of therapy - new drugs. https:\/\/www.ecil-leukaemia.com\/images\/ecil-10\/ECIL_10_-_bacterial_group_final_recommendations.pdf. Accessed 3 Jul 2025"},{"key":"11379_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cid\/ciac005","volume":"75","author":"M Certan","year":"2022","unstructured":"Certan M, Garcia Garrido HM, Wong G et al (2022) Incidence and predictors of community-acquired pneumonia in patients with hematological cancers between 2016 and 2019. Clin Infect Dis 75:1046\u20131053. https:\/\/doi.org\/10.1093\/cid\/ciac005","journal-title":"Clin Infect Dis"},{"key":"11379_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00520-023-08247-8","volume":"32","author":"X Zhang","year":"2024","unstructured":"Zhang X, Huang J-X, Tang M et al (2024) A comprehensive analysis of the association between anemia and systemic inflammation in older patients with cancer. Support Care Cancer 32:39. https:\/\/doi.org\/10.1007\/s00520-023-08247-8","journal-title":"Support Care Cancer"},{"key":"11379_CR41","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ajic.2020.12.001","volume":"49","author":"CB Cosentino","year":"2021","unstructured":"Cosentino CB, Mitchell BG, Brewster DJ, Russo PL (2021) The utility of frailty indices in predicting the risk of health care associated infections: a systematic review. Am J Infect Control 49:1078\u20131084. https:\/\/doi.org\/10.1016\/j.ajic.2020.12.001","journal-title":"Am J Infect Control"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11379-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:03:14Z","timestamp":1792562594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11379"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11379-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Sao Paulo (No. 64052022.4.0000.0068), and the consent form was waived.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1127"}}